Ifiral

Overdose

No overdose data available.

Ifiral price

We have no data on the cost of the drug.
However, we will provide data for each active ingredient

Contraindications

Hypersensitivity, pregnancy, breastfeeding, childhood up to 6 years (eyed drops and drops in the nose) or up to 2 years (inhalation).

Incompatibilities

Reduces the need for ophthalmic drugs containing glucocorticosteroids.

Pharmaceutical form

Drops of eye

Undesirable effects

Eye drops - in rare cases - pinching or burning or foreign body in the eye, conjunctiva edema, hypermia.

Drops in the nose.

From the side of the nervous system and the senses : headache, change in taste.

From the respiratory system : in some cases, hoarse, coughing, suffocation.

Local reactions: in rare cases - sneezing, tingling in the nose, burning sensation, irritation of the nasal mucosa, sometimes - noseble, erosion-lap lesions of the nasal mucosa.

Allergic reactions : in some cases - Quinket edema.

Therapeutic indications

Eye drops - allergic conjunctivitis, keratoconjunctivitis, spring keratoconjunctivitis.

Drops in the nose - allergic rhinitis (seasonal, year-round), polynosis.

Powder for inhalation - bronchial asthma (atopic, physical effort, etc.), chronic bronchitis with bronchopultic syndrome.

Pharmacotherapeutic group

  • Temporal cell membrane stabilizers

Pharmacodynamic properties

Prevents the degradation of fat cells and the separation of histamine, bradikinin, leukotrienes from them (including.h. slowly responding substance) and other biologically active substances. Most effective in preventive use.

Pharmacokinetic properties

Absorption through the mucous membrane of the eyes is negligible. System bioavailability is less than 0.1%. T1/2 - 5-10 minutes.

Special precautions for storage

In a dry place, at temperatures below 30 ° C .

Keep out of the reach of children.

The shelf life of the drug is Ifiral

capsules with inhalation powder 20 mg - 4 years.

snotty drops 2% - 3 years.

eye drops 2% - 3 years.

Do not apply after the expiration date indicated on the package.

Nature and contents of container

1 ml of eye drops or drops in the nose contains sodium of a cromoglycate of 20 mg; in 5 ml dropper bottles, in box 1 bottle.

1 capsule with inhalation powder - 20 mg, in a blister of 10 capsules, in a box of 3 blisters complete with an inhaler.

Nosological classification (ICD-10)

  • J42 Chronic bronchitis unspecified
  • J44 Another chronic obstructive pulmonary disease
  • J45 Asthma

Qualitative and quantitative composition

Sodium Cromoglycate

Dosage (Posology) and method of administration

Eye drops: for adults and children over 6 years old, 1-2 drops in each eye at 6 hours intervals; after achieving the effect, the interval between the installations can be extended.

Drops in the nose: adults with 3-4 drops, children over 6 years old, 1-2 drops in each nose with an interval of 6 hours; treatment course 2-4 weeks.

Powder for inhalation: 20 mg 4 times a day, up to a maximum of 160 mg (8 caps.) using the attached inhaler.

ATC - Anatomical and therapeutic chemical classification

R03BC01 Cromoglycyanic acid